Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,973
datasets available to search
ShareScore release 0.9.0
Dataset results
1,973 results for “T cell receptor”
Long-term Follow-up of Participants Treated With Galapagos Chimeric Antigen Receptor (CAR) T-cell Therapies
ClinicalTrials.gov study NCT06652633. IPD Sharing: NO. Countries: 3. Publications: 0.
A Study of ZN-e4 in Subjects With Epidermal Growth Factor Receptor Mutated Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT03446417. IPD Sharing: NO. Countries: 2. Publications: 0.
Study Using FolateScan to Identify Subjects With Folate Receptor-Positive Metastatic Renal Cell Carcinoma
ClinicalTrials.gov study NCT01689766. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase I Study of Allogeneic Transforming Growth Factor-beta Receptor Type 2 Knockout CD70 CAR NK Cells in Treatment Refractory Clear Cell Renal Cell Carcinoma
ClinicalTrials.gov study NCT07072234. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Osimertinib Combined With Bevacizumab in the Treatment Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions Metastatic Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT04974879. IPD Sharing: NO. Countries: 1. Publications: 0.
Infusion of Autologous T Cells Engineered to Target FSH Receptor in Recurrent Ovarian Cancer
ClinicalTrials.gov study NCT05316129. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Anti-CD22 Chimeric Antigen Receptor (CAR)-Modified T Cell Therapy for Relapsed Refractory B-cell Malignancies
ClinicalTrials.gov study NCT04007978. IPD Sharing: NO. Countries: 1. Publications: 0.
Chimeric Switch Receptor Modified T Cells for Patients With PD-L1+ Recurrent or Metastatic Malignant Tumors
ClinicalTrials.gov study NCT02930967. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
KEYMAKER-U01 Substudy 2: Efficacy and Safety Study of Pembrolizumab (MK-3475) When Used With Investigational Agents in Treatment-naïve Participants With Anti-programmed Cell Death Receptor Ligand 1 (P
ClinicalTrials.gov study NCT04165083. IPD Sharing: YES. Countries: 7. Publications: 0.
Dual Anti-CD22/CD19 Chimeric Antigen Receptor-directed T Cells (CART2219.1) for Relapsed Refractory B-Lineage Leukaemia
ClinicalTrials.gov study NCT05429905. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Mutated or Viral Neoantigens in a Patient With Metastatic Cancer Plus the Administration of Pem
ClinicalTrials.gov study NCT04536922. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Effector and Regulatory T Cell Receptor Repertoire Analyses in Patients Affected by COVID-19
ClinicalTrials.gov study NCT04379466. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Universal Chimeric Antigen Receptor T-Cell （UCAR T-cell） Therapy Targeting CD19/ BCMA（QT-019C） in Patients With r/ r Neurological Autoimmune Diseases
ClinicalTrials.gov study NCT07392528. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Chimeric Antigen Receptor Modified T Cells Targeting BCMA for the Treatment of Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT06581640. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Anti-CD19 Chimeric Antigen Receptor T-Cell Immunotherapy for Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT06364423. IPD Sharing: YES. Countries: 1. Publications: 0.
LANDscape MApping of Epitopes and T Cell Receptors for Selected Cancers
ClinicalTrials.gov study NCT04665388. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
T Cell Receptor Gene-Engineered T Cell Therapy Targeting KRAS Mutations in the Treatment of Subjects With Advanced Solid Tumor
ClinicalTrials.gov study NCT06484556. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of TmPSMA-02 Chimeric Antigen Receptor (CAR) T-cells in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)
ClinicalTrials.gov study NCT05489991. IPD Sharing: Not stated. Countries: 1. Publications: 0.
NKX019, Intravenous Allogeneic Chimeric Antigen Receptor Natural Killer Cells (CAR NK), in Adults With B-cell Cancers
ClinicalTrials.gov study NCT05020678. IPD Sharing: NO. Countries: 2. Publications: 0.
A Phase I Trial of Memory T Cells Expressing an NKG2D Chimeric Antigen Receptor in Children, Adolescents and Young Adults With Advanced Sarcoma
ClinicalTrials.gov study NCT06087341. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.